PRELUDE CAPITAL MANAGEMENT, LLC - NOVAVAX INC ownership

NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 378 filers reported holding NOVAVAX INC in Q1 2022. The put-call ratio across all filers is 1.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of NOVAVAX INC
ValueSharesWeighting
Q4 2021$1,159,000
-31.0%
8,1000.0%0.03%
-30.2%
Q3 2021$1,679,000
+2.7%
8,100
+5.2%
0.04%
-12.2%
Q2 2021$1,635,000
+17.1%
7,7000.0%0.05%
+36.1%
Q1 2021$1,396,000
+172.1%
7,700
+67.4%
0.04%
+176.9%
Q4 2020$513,000
+10160.0%
4,600
+1050.0%
0.01%
Q1 2020$5,0004000.00%
Other shareholders
NOVAVAX INC shareholders Q1 2022
NameSharesValueWeighting ↓
RA Capital Management 2,559,918$543,496,0008.72%
Foresite Capital Management I, LLC 66,810$14,184,0008.55%
Samsara BioCapital, LLC 198,600$42,165,0005.20%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 330,541$70,177,0004.54%
Foresite Capital Management II, LLC 67,373$14,304,0003.85%
Rock Springs Capital Management LP 455,000$96,601,0001.91%
DELTEC ASSET MANAGEMENT LLC 56,320$11,957,0001.65%
Parametrica Management Ltd 10,200$2,166,0001.60%
SECTORAL ASSET MANAGEMENT INC 88,450$18,779,0001.52%
TSP Capital Management Group, LLC 18,525$3,933,0001.29%
View complete list of NOVAVAX INC shareholders